Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Nausea may worsen with insufficient hydration and fast dose escalation
The dosing schedule then continues with incremental increases of 2.5 mg after at least four weeks at each dose level, progressing through the following sequence: 2.5 mg once weekly (weeks 1-4): Initial tolerability dose only 5 mg once weekly (weeks 5-8): Minimum therapeutic dose 7.5 mg once weekly (weeks 9-12): Intermediate dose option 10 mg once weekly (weeks 13-16): Higher therapeutic dose 12.5 mg once weekly (weeks 17-20): Higher therapeutic dose 15 mg once weekly (week 21 onward): Maximum approved dose The FDA label specifies that dose escalation should occur after at least four weeks at each dose level, though clinical judgment may warrant extending this timeline if patients experience significant gastrointestinal symptoms
Read more about other common types of peptides here: Learn more about Palmitoyl Pentapeptide-4 Palmitoyl Tripeptide-5 is a synthetic signal lipopeptide
It helps maintain the health of your intestinal lining, supports nutrient absorption, and aids in reducing muscle breakdown post-exercise
Triple-Hormone-Receptor Agonist Retatrutide for Obesity (PubMed)
